Research
A joint effort between the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) brought $98.35 million to COVID-19 testing efforts this week, as part of six contracts awarded under the Rapid Acceleration of Diagnostics (RADx) initiative.
The... Read More »
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) -- a global non-profit dedicated to antibacterial research – is awarding up to $2.5 million to GangaGen Biotechnologies to develop novel antibacterial proteins.
GangaGen, based in Bangalore, India, will develop... Read More »
National Institute of Standards and Technology (NIST) researchers maintain they have developed a means of increasing primary SARS-CoV-2 virus testing sensitivity to help identify those who are asymptomatic.
Findings published in Analytical and Bioanalytical Chemistry outlined a mathematical... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has partnered with Mapp Biopharmaceutical, Inc. to develop a new monoclonal antibody therapeutic for all seven major types of Botulinum Neurotoxin.
Botulinum is an incredibly lethal substance responsible for botulism, though it... Read More »
With an initial five laboratories, the Coalition of Epidemic Preparedness Innovations (CEPI) has launched a network of labs worldwide, collectively focused on helping COVID-19 vaccine developers uniformly evaluate and identify successful candidates.
By centralizing, the hope is to assess and... Read More »
The U.S. Agency for International Development (USAID) has selected Tufts University to spearhead a $100 million program to assess and address zoonotic viral disease threats such as SARS-CoV-2.
The effort would target spillover from animals to humans to reduce the risk of infection,... Read More »
As part of a community-focused move, particularly among schools, the United States Department of Health and Human Services (HHS) and The Rockefeller Foundation have agreed to identify and share effective approaches for using rapid point-of-care antigen tests to screen for COVID-19.
The pilot... Read More »
A pair of investigational drugs targeting antibiotic-resistant infections will receive nearly $20 million in initial funding from the Biomedical Advanced Research and Development Authority (BARDA) to support phase two and three clinical trials and other efforts to reach U.S. Food and Drug... Read More »
The United Nations reported a major milestone this week for the global Access to COVID-19 Tools (ACT) Accelerator initiative, collecting nearly $1 billion in new financing to guarantee tests, treatment and vaccines for COVID-19.
The ACT Accelerator is a joint effort by the World Health... Read More »
The Denver Health and Hospital Authority signed a $3 million cooperative agreement with the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) to demonstrate the effectiveness of a Regional Disaster Health Response System... Read More »
The Department of Homeland Security’s (DHS) Small Business Innovation Research (SBIR) Program has awarded $1.96 million to a pair of businesses to aid emergency communication network risk management assessments.
Orem, Utah-based Achilles Heel Technologies and SecureLogix, of San Antonio,... Read More »
A phase one trial of a COVID-19 vaccine jointly developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna, Inc. brought positive results, triggering strong immune responses among older volunteers while proving well-tolerated.
According to a report published this... Read More »
BARDA is partnering with Inversa to develop a treatment for eye problems associated with DNA damage, particularly those caused by chemical agents like sulfur mustard gas.
Ingrained in the public mind since its widespread use in WWI, sulfur mustard is a means of chemical warfare that causes the... Read More »
A new report from the Nuclear Threat Initiative (NTI) says some gaps need to be addressed in the international system to prevent and respond to biological events.
NTI is calling on national and global leaders to take action now to prevent future biological events that could match or exceed the... Read More »
Victoria Coleman, appointed as the Defense Advanced Research Projects Agency’s (DARPA) 22nd director, received the oath of office from Acting Under Secretary of Defense for Research and Engineering Michael Kratsios.
Coleman, who most recently served as senior advisor on microelectronics... Read More »
Kynamics of Mountain View, Calif., has secured a Department of Homeland Security (DHS) Science and Technology Directorate’s (S&T) Silicon Valley Innovation Program (SVIP) language translation capabilities funding award.
The $192,520 in Phase 1 funding would yield a portable, standalone... Read More »
In an effort to better track COVID-19 infections, the Luminex Corporation and the Biomedical Advanced Research and Development Authority (BARDA) have partnered on the creation of a more advanced serology test.
This latest effort is based on the xMAP SARS-CoV-2 Multi-Antigen IgG assay, a... Read More »
A new, phase three clinical trial for Janssen Pharmaceutical Companies’ investigational COVID-19 vaccine began recruiting adult volunteers this week to see if a single dose could prevent symptomatic cases.
The trial will enroll up to 60,000 volunteers at nearly 215 clinical research sites in... Read More »
Sen. Tammy Duckworth (D-IL) expressed gratitude to the Government Accountability Office (GAO) after the agency officially accepted her request to conduct an independent review of federal agencies' less-lethal weapons use.
Duckworth joined a group of lawmakers requesting the GAO to assess the... Read More »
As part of a 250-325 household study spanning three countries, The Saban Research Institute of Children’s Hospital Los Angeles will participate in a $7.1 million effort to investigate some of the unanswered questions surrounding COVID-19 and influenza transmission.
Among those questions being... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) expanded its partnership with Ortho Clinical Diagnostics to accelerate the development of a COVID-19 antigen test.
The Vitros antigen test is designed for the rapid detection of the virus that causes COVID-19. It is intended for... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) has joined University of Pennsylvania researchers from two labs to build lung-on-a-chip technology, which promises a safe means of studying chlorine gas effects and the discovery of treatments.
Chlorine gas was used as a weapon... Read More »
The Nuclear Threat Initiative (NTI) convened a meeting of more than 40 experts worldwide to address the need for better oversight of biotechnology research.
Biotechnology research is essential for reducing pandemic threats and supporting global health. However, scientific advances in the life... Read More »
More than 90 organizations representing scientists, physicians, health providers, as well as patients and medical advocates are urging the U.S. Food and Drug Administration to ensure that reviews of COVID-19 vaccine candidates meet all regulatory standards prior to authorization.
“While we are... Read More »
Eli Lilly and Company announced a new collaboration with Amgen last week that will allow a significant increase in supply capacity and scaling of production of its potential COVID-19 therapies.
The news came a mere day after Lilly announced that proof of concept data from its BLAZE-1 clinical... Read More »
The National Institutes of Health (NIH) is looking to innovate in terms of COVID-19 tools, and as a result, has awarded seven contracts to a mix of companies and academic institutions for things like smartphone apps, wearable devices, and software.
These technologies could aid in several... Read More »
America’s top public health officials earlier Wednesday briefed U.S. Senate subcommittee members on two documents outlining the Trump administration’s strategy to distribute over the next several months safe, effective and free COVID-19 vaccines to Americans as quickly as possible once the Food... Read More »
With the development of the drug ganaxolone (GNX), Marinus Pharmaceuticals and BARDA hope to create an anticonvulsant capable of halting damaging seizures in their tracks, even those caused by deadly nerve agents like the odorless, colorless liquid, Sarin.
Some seizures have proven resilient to... Read More »
Phase three trials have resumed for the AstraZeneca-Oxford COVID-19 vaccine, AZD1222, after pausing for safety concerns raised when an enrollee came down with an unexplained illness that was later determined to be unrelated to the experimental vaccine.
One of the leading candidates in the... Read More »
The development of a diagnostic tool for assessing, diagnosing, reporting, and tracking COVID-19 patients by 98point6 is now being supported by the Biomedical Advanced Research and Development Authority (BARDA).
The tool, originally used to treat and track influenza infections, also utilizes a... Read More »
A new report says investment in data and artificial intelligence (AI) is needed to drive the health system improvements needed to respond to and recover from the COVID-19 pandemic.
The study – called Reimagining Global Health through Artificial Intelligence: The Roadmap to AI Maturity -- was... Read More »
International Air Transport Association (IATA) officials maintain governments should initiate planning with the industry to ensure preparedness when COVID-19 vaccines are approved and ready for distribution.
“Safely delivering COVID-19 vaccines will be the mission of the century for the... Read More »
A top COVID-19 vaccine candidate being developed by AstraZeneca and Oxford University was forced to halt phase 3 trials this week after a volunteer became ill, signaling an adverse reaction that could delay the effort at immunization development.
The pause was announced as a standard review of... Read More »
The Infectious Diseases Society of America (IDSA) issued guidance for the clinical treatment of three of the most common drug-resistant pathogens.
While antibiotics save lives, the bacteria and other microbes can evolve in ways that enable them to resist a drug’s intended effect. Misuse or... Read More »
Amid fears of political pressures to rush a vaccine for COVID-19, nine CEOs of biopharmaceutical companies working on these candidates have signed a pledge to uphold the scientific process and safety in any development.
The companies include AstraZeneca, BioNTech, GlaxoSmithKline plc, Johnson &... Read More »
